Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients

The oral microbiome has emerged as a critical biomarker and regulator in cancer development and treatment response, garnering increasing attention from researchers. However, its specific role in breast cancer, particularly in triple-negative breast cancer (TNBC), remains poorly understood. The influ...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Xiaoyan Fu, Ze Huang, Zongyan Li, Zuxiao Chen, Zhijie Wu, Qingyu Yang, Haiyan Li
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2025-07-01
Rangatū:	Frontiers in Oncology
Ngā marau:	oral microbiome triple-negative breast cancer neoadjuvant chemotherapy sensitivity response-prediction model biomarker
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1546044/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!